eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
4/2024
vol. 41
 
Share:
Send email
Share:
Original paper

Increased expression of psoriasin (S100A7) and interleukin 17 (IL-17) in lesional skin in lichen planopilaris

Agnieszka Otlewska-Szpotowicz
1
,
Wojciech Baran
1
,
Zdzisław Woźniak
2
,
Jacek Szepietowski
1
,
Aleksandra Batycka-Baran
1

  1. Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, Wroclaw, Poland
  2. Department of Clinical and Experimental Pathology, Wroclaw Medical University, Wroclaw, Poland
Adv Dermatol Allergol 2024; XLI (4): 364-371
DOI: https://doi.org/10.5114/ada.2024.142179
Online publish date: 2024/08/12
Article file
- Increased (6).pdf  [0.31 MB]
Get citation
 
 
1. Lin J, Saknite I, Valdebran M, et al. Feature characterization of scarring and non-scarring types of alopecia by multiphoton microscopy, Lasers Surg Med 2019; 51: 95-103.
2. Alessandrini A, Bruni F, Piraccini BM et al. Common causes of hair loss – clinical manifestations, trichoscopy and therapy. J Eur Acad Dermatol Venereol 2021; 35: 629-40.
3. Meinhard J, Stroux A, Lünnemann L, et al. Lichen planopilaris: epidemiology and prevalence of subtypes – a retrospective analysis in 104 patients. J Dtsch Dermatol Ges 2014; 12: 229-36.
4. Rácz E, Gho C, Moorman PW, et al. Treatment of frontal fibrosing alopecia and lichen planopilaris: a systematic review. J Eur Acad Dermatol Venereol 2013; 27: 1461-70.
5. Ramot Y, Marzani B, Pinto D, et al. IL-17 inhibition: is it the long-awaited savior for alopecia areata? Arch Dermatol Res 2018; 310: 383-90.
6. Svigos K, Yin L, Fried L, et al. A practical approach to the diagnosis and management of classic lichen planopilaris. Am J Clin Dermatol 2021; 22: 681-92.
7. Errichetti E, Figini M, Croatto M, et al. Therapeutic management of classic lichen planopilaris: a systematic review. Clin Cosmet Investig Dermatol 2018; 11: 91-102.
8. Kang H, Alzolibani AA, Otberg N, et al. Lichen planopilaris. Dermatol Ther 2008; 21: 249-56.
9. Gautam RK, Singh Y, Gupta A, et al. The profile of cytokines (IL-2, IFN-g, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata. J Cosmet Dermatol 2020; 19: 234-40.
10. Tavakolpour S, Mahmoudi H, Abedini R, et al. Frontal fibrosing alopecia: an update on the hypothesis of pathogenesis and treatment. Int J Womens Dermatol 2019; 5: 116-23.
11. Eckert RL, Broome AM, Ruse M, et al. S100 proteins in the epidermis. J Invest Dermatol 2004; 123: 23-33.
12. Bresnick AR. S100 proteins as therapeutic targets. Biophys Rev 2018; 10: 1617-29.
13. Donato R. Intracellular and extracellular roles of S100 proteins. Microsc Res Tech 2003; 60: 540-51.
14. Wolf R, Ruzicka T, Yuspa SH. Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function. Amino Acids 2011; 41: 789-96.
15. Reithmayer K, Meyer KC, Kleditzsch P, et al. Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7. Br J Dermatol 2009; 161: 78-89.
16. Watson PH, Leygue ER, Murphy LC, et al. Psoriasin (S100A7). Int J Biochem Cell Biol 1998; 30: 567-71.
17. Wolf R, Howard OM, Dong HF, et al. Chemotactic activity of S100A7 (Psoriasin) is mediated by the receptor for advanced glycation end products and potentiates inflammation with highly homologous but functionally distinct S100A15. J Immunol 2008; 181: 1499-506.
18. Batycka-Baran A, Baran W, Nowicka-Suszko D, et al. Serum concentration and skin expression of S100A7 (Psoriasin) in patients suffering from hidradenitis suppurativa. Dermatology 2021; 237: 733-9.
19. Gonzalez LL, Garrie K, Turner MD, et al. Role of S100 proteins in health and disease. Biochim Biophys Acta Mol Cell Res 2020; 1867: 118677.
20. Hegyi Z, Zwicker S, Bureik D, et al. Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 “alarmins” psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. J Invest Dermatol 2012; 132: 1416-24.
21. Gross SR, Sin CG, Barraclough R, et al. Joining S100 proteins and migration: for better or for worse, in sickness and in health. Cell Mol Life Sci 2014; 71: 1551-79.
22. Li Z, Li Y, Liu S, et al. Extracellular S100A4 as a key player in fibrotic diseases. J Cell Mol Med 2020; 24: 5973-83.
23. Ambartsumian N, Klingelhöfer J, Grigorian M, et al. The multifaceted S100A4 protein in cancer and inflammation. Methods Mol Biol 2019; 1929: 339-65.
24. Tomcik M, Palumbo-Zerr K, Zerr P, et al. S100A4 amplifies TGF-b-induced fibroblast activation in systemic sclerosis. Ann Rheum Dis 2015; 74: 1748-55.
25. Zibert JR, Skov L, Thyssen JP, et al. Significance of the S100A4 protein in psoriasis. J Invest Dermatol 2010; 130: 150-60.
26. Schneider M, Hansen JL, Sheikh SP. S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases. J Mol Med (Berl) 2008; 86: 507-22.
27. Liu T, Li S, Ying S, et al. The IL-23/IL-17 Pathway in inflammatory skin diseases: from bench to bedside. Front Immunol 2020; 11: 594735.
28. Żychowska M, Batycka-Baran A, Baran W. Increased serum level and high tissue immunoexpression of interleukin 17 in cutaneous lichen planus: a novel therapeutic target for recalcitrant cases. Dis Markers 2020; 2020: 6521274.
29. Michalak-Stoma A, Bartosińska J, Kowal M, et al. IL-17A in the psoriatic patients’ serum and plaque scales as potential marker of the diseases severity and obesity. Mediators Inflamm 2020; 2020: 7420823.
30. Porriño-Bustamante ML, Fernández-Pugnaire MA, Arias-Santiago S. Frontal fibrosing alopecia: a review. J Clin Med 2021; 10: 1805.
31. Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med 2012; 366: 1515-25.
32. Poblet E, Jiménez F, Pascual A, et al. Frontal fibrosing alopecia versus lichen planopilaris: a clinicopathological study. Int J Dermatol 2006; 45: 375-80.
33. Cerqueira ER, Valente N, Sotto MN, et al. Comparative analysis of immunopathological features of lichen planopilaris and female patients with frontal fibrosing alopecia. Int J Trichology 2016; 8: 197-202.
34. Tayyebi Meibodi N, Asadi Kani F, Nahidi Y, et al. Lichen planopilaris: histopathological study of vertical sections of scalp biopsies in 44 patients. Iran Red Crescent Med J 2012; 14: 501-2.
35. Pinto D, Calabrese FM, De Angelis M, et al. Lichen planopilaris: the first biopsy layer microbiota inspection. PLoS One 2022; 17: e0269933.
36. Batycka-Baran A, Hattinger E, Zwicker S, et al. Leukocyte-derived koebnerisin (S100A15) and psoriasin (S100A7) are systemic mediators of inflammation in psoriasis. J Dermatol Sci 2015; 79: 214-21.
37. Xia C, Braunstein Z, Toomey AC, et al. S100 proteins as an important regulator of macrophage inflammation. Front Immunol 2018; 8: 1908.
38. Ge Y, Huang M, Yao YM. Biology of interleukin-17 and its pathophysiological significance in sepsis. Front Immunol 2020; 11: 1558.
39. Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg 2009; 28: 3-10.
40. Shahidi Dadras M, Rakhshan A, Dadkhahfar S, et al. The role of interleukin-17 (IL-17) in the pathogenesis of discoid lupus erythematosus and lichen planopilaris: is immunohistochemistry for IL-17 a promising way to differentiate these entities?. Int J Dermatol 2022; 61: 647-52.
41. Miteva M, Nadji M, Billero V, et al. IL-17 expression in the perifollicular fibrosis in biopsies from lichen planopilaris. Am J Dermatopathol 2022; 44: 874-8.
42. Dy LC, Whiting DA. Histopathology of alopecia areata, acute and chronic: why is it important to the clinician? Dermatol Ther 2011; 24: 369-74.
43. Tomaszewska KA, Kozłowska M, Kaszuba A, et al. Increased serum levels of interleukin-17 in patients with alopecia areata and non-segmental vitiligo. Adv Dermatol Alergol 2022; 39: 195-9.
44. Atwa MA, Youssef N, Bayoumy NM. T-helper 17 cytokines (interleukins 17, 21, 22, and 6, and tumor necrosis factor-a) in patients with alopecia areata: association with clinical type and severity. Int J Dermatol 2016; 55: 666-72.
45. Bain KA, McDonald E, Moffat F, et al. Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity. Br J Dermatol 2020; 182: 130-7.
46. Loh SH, Moon HN, Lew BL, et al. Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients. J Eur Acad Dermatol Venereol 2018; 32: 1028-33.
47. Elela MA, Gawdat HI, Hegazy RA, et al. B cell activating factor and T-helper 17 cells: possible synergistic culprits in the pathogenesis of alopecia areata. Arch Dermatol Res 2016; 308: 115-21.
48. Tanemura A, Oiso N, Nakano M et al. Alopecia areata: infiltration of Th17 cells in the dermis, particularly around hair follicles. Dermatology 2013; 226: 333-6.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.